Previous 10 | Next 10 |
SAN DIEGO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with oth...
Tracon press release ( NASDAQ: TCON ): Q3 GAAP EPS of -$0.30 beats by $0.02 . Cash and cash equivalents were $17.0M at September 30, 2022, compared to $24.1M at December 31, 2021, and is expected to fund the company into mid-2023. For further details see: Tra...
TRACON Pharmaceuticals, Inc. (TCON) Q3 2022 Earnings Conference Call November 14, 2022, 16:30 ET Company Participants Charles Theuer - CEO, President & Director Scott Brown - CFO Conference Call Participants Joel Beatty - Robert W. Baird & Co. ...
SAN DIEGO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with oth...
SAN DIEGO, Oct. 31, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with oth...
Summary Beijing AIM Vaccine conducted a very small IPO on the Hong Kong exchange, raising just US$20 million, which netted the company only US$10 million. Interest in the offering was low, with less than 1% of the company shares sold in the offering. Shanghai SciClone Pharma has b...
Completed Nine Investments in New and Existing Portfolio Companies Representing $216 Million in New Commitments and $161 Million in Funded Loans Total Loan Commitments and Funded Investments Grew to $2.0 Billion and $1.6 Billion Since Inception WOODSIDE, Calif., Oct. 06, 2022 (G...
SAN DIEGO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with oth...
Cancer-focused biotech Tracon Pharmaceuticals ( NASDAQ: TCON ) announced Wednesday that the FDA granted fast-track designation for envafolimab (KN035) as a treatment for patients with connective tissue tumors pleomorphic sarcoma (UPS) and myxofibrosarcoma (MFS). TCON shares ...
SAN DIEGO, Sept. 14, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with ot...
News, Short Squeeze, Breakout and More Instantly...
TRACON Pharmaceuticals Inc. Company Name:
TCON Stock Symbol:
NASDAQ Market:
TRACON Pharmaceuticals Inc. Website:
A look at the top 10 most actives in the United States Yoshitsu Co. Ltd (TKLF) rose 103.4% to $0.623 on volume of 309,019,720 shares Maxeon Solar Technologies Ltd. (MAXN) rose 11.2% to $0.2524 on volume of 226,231,487 shares NVIDIA Corporation (NVDA) fell 1.6% to $126.36 on volume of 208,...
A look at the top 10 most actives in the United States American Rebel Holdings Inc. (AREB) rose 60.3% to $0.83355 on volume of 56,112,820 shares DatChat Inc. (DATS) rose 71.2% to $1.78 on volume of 33,845,116 shares Autonomix Medical Inc. (AMIX) rose 97.4% to $1.22 on volume of 33,054,234...
A look at the top 10 most actives in the United States Maxeon Solar Technologies Ltd. (MAXN) rose 35.3% to $0.3248 on volume of 164,333,109 shares SRIVARU Holding Limited (SVMH) rose 62.4% to $0.2581 on volume of 68,213,933 shares NVIDIA Corporation (NVDA) rose 2.9% to $129.43 on volume o...